Dr. Samuel Waxman: Curing Cancer, the Next 50 Years

Mount Sinai Scientists Create AI-Powered Tool to Improve Cancer Tissue Analysis

Combination Therapy Improves Outcomes for Advanced Triple-Negative Breast Cancer

Mount Sinai Researchers Pioneer First Targeted Therapy for Rare T-Cell Lymphoma After CAR T Treatment

Mount Sinai Receives $4 Million Grant From American Cancer Society to Launch Cancer Health Research Center

The Mount Sinai Hospital Ranked Among Top in the Nation by U.S. News & World Report®

Mount Sinai Researchers Engineer Rare Immune Cells to Create Powerful New Cancer Vaccine

Mount Sinai Researchers Discover Link Between Metabolism and Protective Effect of Breastfeeding Against Breast Cancer

Mount Sinai Researcher Publishes Landmark Studies Advancing Treatment for Rare and Aggressive Lymphoma

Mount Sinai and Cancer Research Institute Team Up to Improve Patient Outcomes in Immunotherapy

Mount Sinai’s Cancer Science in the Spotlight at 2025 ASCO

Mount Sinai Study Advances Understanding of Personalized Vaccines for Bladder Cancer